Other Treatments of Autoimmune Hepatitis

People who do not respond to standard immune therapy or who have severe side effects may benefit from other immunosuppressive agents like mycophenylate mofetil, cyclosporine or tacrolimus. People who progress to end stage liver disease (liver failure) and/or cirrhosis may need a liver transplant. Transplantation has a 1-year survival rate of 90 percent and a 5-year survival rate of 70 to 80 percent.

source: http://digestive.niddk.nih.gov/ddiseases/pubs/autoimmunehep/index.htm